AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Tipranks

Published November 9, 2026

PharmAla Signs MDMA Supply and Data Agreement for Danish PTSD Trial - TipRanks.com

Read the full story at Tipranks

An announcement from PharmAla Biotech Holdings, Inc. ( ($TSE: MDMA ) ) is now available. PharmAla Biotech has signed an agreement with Aalborg.

Post on X

Share this story

Surfaced by this Google Alert

MDMA